Infantile hemangioma (IH) is the most common benign vascular tumor in infants and children under one year of age. 12% with IH have a tendency to develop dangerous complications, development which depends on area localization, its size, growth rate, patient's Careful history taking physical examination make it possible verify located critical localization zones (physiological openings, neck, pal...

β-Adrenergic and angiotensin II type 1A receptors are therapeutic targets for the treatment of a number of common human diseases. Pharmacological agents designed as antagonists for these receptors have positively affected the morbidity and mortality of patients with hypertension, heart failure, and renal disease. Antagonism of these receptors, however, may only partially explain the therapeutic...

β-Adrenergic signaling is involved in many processes that may contribute to cancer progression. In this issue of the journal (beginning on page 1007), Nkontchou and colleagues report their retrospective observational finding that the β-blocker propranolol was associated with a highly statistically significant reduction in the incidence of hepatocellular carcinoma in patients with advanced cirrh...

Background: A recent meta-analysis of drug effects in patients with hypertension claims that all β-adrenergic blockers are equally effective but less so than other antihypertensive drugs. Published comparisons of the β-adrenergic blocker atenolol and non-atenolol β-adrenergic blockers indicate different effects on death rates, arrhythmias, peripheral vascular resistance and prognosis post myoca...

Hypertensive crises (HCs) are common occurrences and can result in immediate or delayed organ damage. Given the complex pathophysiological process associated with HCs, selecting appropriate treatment be a challenge. The goal of this report is to provide nurse practitioners an up-to-date evidence-based mnemonic tool help effectively manage HCs. Using alphabetized provides quick recall into optio...

1. Prev ntion of Cardiovascular Events in Patients With Hypertension and CAD 1.1. Antihypertensive Drugs for the Secondary Prevention of Cardiovascular Events in Patients With CAD 1.1.1. Thiazide and ThiazideType Diuretics 1.1.2. β-Blockers 1.1.3. ACE Inhibitors 1.1.4. Angiotensin Receptor Blockers 1.1.5. Aldosterone Antagonists 1.1.6. Calcium Channel Blockers 1.1.7. Direct Renin Inhibitors 2. ...